Systematic Comparison of Methods for Determining the in vivo Biodistribution of Porous Nanostructured Injectable Inorganic Particles
暂无分享,去创建一个
M. Ferrari | Elvin Blanco | S. Nizzero | Haifa Shen | J. Mai | Guodong Zhang | Feng Li | Zheng Li | A. Venuta | Carlotta Borsoi | Joy Wolfram
[1] C. Brinker,et al. Establishing the effects of mesoporous silica nanoparticle properties on in vivo disposition using imaging-based pharmacokinetics , 2018, Nature Communications.
[2] M. Ferrari,et al. Alternating block copolymer-based nanoparticles as tools to modulate the loading of multiple chemotherapeutics and imaging probes. , 2018, Acta biomaterialia.
[3] M. Zyuzin,et al. Porous Inorganic Carriers Based on Silica, Calcium Carbonate and Calcium Phosphate for Controlled/Modulated Drug Delivery: Fresh Outlook and Future Perspectives , 2018, Pharmaceutics.
[4] Doug W. Smith,et al. Advantages and Limitations of Current Techniques for Analyzing the Biodistribution of Nanoparticles , 2018, Front. Pharmacol..
[5] S. Nizzero,et al. Ultra-small dye-doped silica nanoparticles via modified sol-gel technique , 2018, Journal of Nanoparticle Research.
[6] Mauro Ferrari,et al. Transport Barriers and Oncophysics in Cancer Treatment. , 2018, Trends in cancer.
[7] Doug W. Smith,et al. Advantages and Limitations of Current Imaging Techniques for Characterizing Liposome Morphology , 2018, Front. Pharmacol..
[8] M. Ferrari,et al. A chloroquine-induced macrophage-preconditioning strategy for improved nanodelivery , 2017, Scientific Reports.
[9] Ian D. McGilvray,et al. Mechanism of hard nanomaterial clearance by the liver , 2016, Nature materials.
[10] A. J. Tavares,et al. Analysis of nanoparticle delivery to tumours , 2016 .
[11] Mauro Ferrari,et al. An injectable nanoparticle generator enhances delivery of cancer therapeutics , 2016, Nature Biotechnology.
[12] Anne L. van de Ven,et al. Cell source determines the immunological impact of biomimetic nanoparticles. , 2016, Biomaterials.
[13] Mauro Ferrari,et al. Principles of nanoparticle design for overcoming biological barriers to drug delivery , 2015, Nature Biotechnology.
[14] Ester Segal,et al. Mechanism of erosion of nanostructured porous silicon drug carriers in neoplastic tissues , 2015, Nature Communications.
[15] M. Ferrari,et al. Porous silicon microparticles for delivery of siRNA therapeutics. , 2015, Journal of visualized experiments : JoVE.
[16] M. Ferrari,et al. Degradation and biocompatibility of multistage nanovectors in physiological systems. , 2014, Journal of biomedical materials research. Part A.
[17] M. Ferrari,et al. Bone marrow endothelium-targeted therapeutics for metastatic breast cancer. , 2014, Journal of controlled release : official journal of the Controlled Release Society.
[18] P Olivero,et al. Beating the Abbe diffraction limit in confocal microscopy via nonclassical photon statistics. , 2014, Physical review letters.
[19] M. Ferrari,et al. High capacity nanoporous silicon carrier for systemic delivery of gene silencing therapeutics. , 2013, ACS nano.
[20] Mauro Ferrari,et al. Porous silicon advances in drug delivery and immunotherapy. , 2013, Current opinion in pharmacology.
[21] M. Ferrari,et al. Discoidal Porous Silicon Particles: Fabrication and Biodistribution in Breast Cancer Bearing Mice , 2012, Advanced functional materials.
[22] Mauro Ferrari,et al. Rapid tumoritropic accumulation of systemically injected plateloid particles and their biodistribution. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[23] Mauro Ferrari,et al. Tailored porous silicon microparticles: fabrication and properties. , 2010, Chemphyschem : a European journal of chemical physics and physical chemistry.
[24] Mauro Ferrari,et al. Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications. , 2008, Nature nanotechnology.
[25] J. Capeau,et al. Haemoglobin interferes with the ex vivo luciferase luminescence assay: consequence for detection of luciferase reporter gene expression in vivo , 2000, Gene Therapy.